Skip to main content
Advertisement
  • Loading metrics

High-resolution structures of malaria parasite actomyosin and actin filaments

Abstract

Malaria is responsible for half a million deaths annually and poses a huge economic burden on the developing world. The mosquito-borne parasites (Plasmodium spp.) that cause the disease depend upon an unconventional actomyosin motor for both gliding motility and host cell invasion. The motor system, often referred to as the glideosome complex, remains to be understood in molecular terms and is an attractive target for new drugs that might block the infection pathway. Here, we present the high-resolution structure of the actomyosin motor complex from Plasmodium falciparum. The complex includes the malaria parasite actin filament (PfAct1) complexed with the class XIV myosin motor (PfMyoA) and its two associated light-chains. The high-resolution core structure reveals the PfAct1:PfMyoA interface in atomic detail, while at lower-resolution, we visualize the PfMyoA light-chain binding region, including the essential light chain (PfELC) and the myosin tail interacting protein (PfMTIP). Finally, we report a bare PfAct1 filament structure at improved resolution.

Author summary

We present the structure of the malaria parasite motor complex:actin 1 (PfAct1) and myosin A (PfMyoA) with its two light chains. We also report a high-resolution structure of filamentous PfAct1 that reveals new atomic details of the ATPase site, including a solvent-filled cavity. PfAct1 undergoes no conformational changes upon PfMyoA binding. The PfMyoA structure in the complex superimposes with a recent crystal structure of PfMyoA although small, but significant, structural rearrangements occur at the actomyosin binding interface.

Introduction

Malaria parasites belong to the phylum Apicomplexa, which are obligate intracellular parasites many of which infect humans and livestock, with devastating effects on human health and mortality and large economic losses worldwide [1]. Among the best-known members of the phylum are Plasmodium spp. (the causative agents of malaria), Toxoplasma gondii (toxoplasmosis), and Cryptosporidium spp. (gastrointestinal and respiratory cryptosporidiosis), all life-threatening human pathogens. Apicomplexan parasites are dependent on an actomyosin based motor system that drives gliding motility that they use to invade and egress from cells of the host organisms [2,3]. The motor complex, called the glideosome, is located in a narrow space between the parasite plasma membrane and an inner membrane complex (IMC), which is structurally unique to this class of parasites [24].

Myosins are a large and diverse family of motor proteins, with >30 classes, found across all eukaryotic organisms [5]. Although the myosin classes are functionally and structurally distinct, they share several conserved domains [6,7] and produce force and movement via the same basic mechanism, making cyclical interactions with actin, coupled to the break-down of ATP to ADP and inorganic phosphate (Pi). Most myosins characterized to date move towards the plus-end of actin filaments, with the exception of the reverse-directed, class VI myosins. The myosin heavy chain consists of an N-terminal motor domain that is well-conserved and contains the catalytic site and actin binding site, which attaches and releases actin during the ATPase-cycle. The motor domain is followed by a “neck” region, which binds one or more calmodulin-like light chains. This region is functionally important because structural rearrangements within the motor domain cause it to rotate through a large angle (>60°), and it acts as a lever arm to amplify the motion, producing the active “power stroke”. Class VI myosins have a unique insert within the neck sequence that reverses the power stroke direction. Following the neck region, most myosins have an extended, C-terminal “tail”, which is highly diverse in both sequence and structure and is responsible for targeting the motor to its cellular cargo. Some myosins have a coiled-coil forming region within the tail that causes the heavy chains to dimerize [8].

Plasmodium spp. have six myosin genes: three parasite-specific class XIV myosins, two reverse-directed class VI myosins, and one class XXII myosin [9]. One of the class XIV myosins, PfMyoA, is essential for gliding motility and is the best-characterized of the parasite myosins. It is unusually small, consisting of just the canonical motor domain and neck region that bears two light chains: essential light chain (PfELC) and myosin tail interacting protein (PfMTIP) [10,11]. As PfMyoA completely lacks a tail region, it is thought to be unable to dimerize on its own. PfMyoA is anchored via MTIP to the IMC by binding two lipid-modified glideosome-associated proteins (PfGAP45 and PfGAP50) [12]. To generate gliding motility, PfMyoA interacts with PfAct1 filaments [1315] that are linked to the plasma membrane via the glideosome-associated connector (GAC; [16]), which binds to transmembrane adhesins of the thrombospondin-related anonymous protein family [17]. During gliding, PfMyoA moves along actin, pulling the IMC towards the anterior (front end) of the parasite, while pushing the actin filaments and associated plasma membrane, rearwards [18]. X-ray crystal structures have been determined for the truncated motor domains of PfMyoA ortholog from T. gondii [19], P. falciparum MyoA [20], full-length PfMyoA decorated with PfELC and PfMTIP [21], trimeric complexes of the tail segment and light chains: PfELC and PfMTIP [22],and finally a cryo-EM structure of motor domain decorated actin [23]. For brevity, herein we refer to the P. falciparum proteins without the species-specific prefix “Pf”.

Apicomplexan actins differ from the well-characterized canonical actins from yeasts, plants, and animals in some important aspects. While canonical actins form filaments, which can be micrometers to tens of micrometers in length, apicomplexan actin filaments in similar in vitro conditions are short, typically around 100 nm [14,15,24]. Nevertheless, they contain intrinsic capacity to form tens of micrometer long filaments in high micromolar concentrations in vitro [25]. In malaria parasites, visualization of filamentous actin has been elusive, and recently work with actin-chromobodies visualized actin networks at different development stages [26]. For T. gondii actin, an isodesmic polymerization mechanism was suggested to be the reason behind the short filament length [27]. However, we have shown that the polymerization pathway and kinetics of Act1 are very similar to canonical actins [24], and the short length of the filaments is likely caused by a high fragmentation rate [28]. In a recent study based on TIRF microscopy, it was suggested that the critical concentration for polymerization of Act1 is at least an order of magnitude higher than that of canonical actins [25]. Also the link between ATP hydrolysis and polymerization seems to be different in apicomplexan compared to canonical actins [15,24,28]. Whereas canonical actins polymerize preferably in the ATP form and only catalyze ATP hydrolysis in the filamentous (F) form, ATP hydrolysis in the monomer causes Plasmodium actins to form short oligomers [15]. These observations indicate that there may be differences in the catalytic mechanism of ATP hydrolysis and in the activation of polymerization between the apicomplexan and higher eukaryotic actins.

Malaria parasites go through several transformations between very different cell types during their life cycle, and some of these forms show rapid and highly directed movement. Merozoites penetrate red blood cells in seconds, the midgut-penetrating ookinetes can move at ~5 μm/min [29] and the mosquito-transmitted sporozoites move with an impressive average speeds of 1–2 μm/s for tens of minutes [30]. Recently, it was proposed that the speed and force generation of MyoA are fine-tuned by phosphorylation of Ser19 in the N-terminal helix [20]. In addition, the light chains are required for maximal speed as measured by in vitro actin-gliding assays [10,11]. The spatial relationship between the full-length MyoA:ELC:MTIP complex and its binding partner, filamentous actin, is necessary in order to understand the role of the light chains in determining force, speed, and step size of the motor complex as well as its association with the glideosome complex.

Here, we report the structure of full-length MyoA, with its ELC and MTIP light chains, bound to the Act1 filament and a new high-resolution structure of the non-decorated Act1 filament. Our high-resolution structures show interactions at the PfAct1:PfMyoA binding interface and the positioning of the two light chains (ELC and MTIP) on the MyoA neck region. Additionally, we characterize the common mode of binding to actin for different classes of myosin despite divergent amino acids at the binding interface.

Results and discussion

High-resolution structures of malaria parasite actomyosin and actin filaments

We reconstituted the malaria parasite actomyosin filament in the rigor state in vitro using recombinantly expressed Act1 and MyoA:ELC:MTIP complex in the presence of a small cyclic peptide, jasplakinolide, which stabilizes actin filaments and has been used for cryo-EM studies on Act1 filaments previously [13,15,23]. After plunge-freezing and cryo-EM imaging, we observed three types of filaments: bare Act1 filaments and filaments either partially or fully decorated by the MyoA:ELC:MTIP complex. By picking well-decorated filaments from the micrographs (S1 Fig), we determined the malaria parasite actomyosin structure using helical reconstruction methods [31] to an overall resolution of 3.1 Å, as estimated by Fourier shell correlation with the 0.143 threshold criterion (Figs 1 and S1 and Table 1).

thumbnail
Fig 1. High-resolution reconstructions of filamentous Act1 (left) and MyoA-decorated Act1 (right).

In the density maps, the central individual actin protomers and myosins are depicted in different colors. Jasplakinolide (JAS) and ADP are shown in red and yellow, respectively. The top middle part shows density maps around individual protein molecules and small molecule ligands as labeled. The bottom row shows density maps of selected structural motifs, as labeled, within the interfaces in the complexes. Additionally, density around phosphorylated Ser19 (S19-P) is shown.

https://doi.org/10.1371/journal.ppat.1010408.g001

For direct comparison, we also determined the structure of the non-decorated Act1 filament at an average resolution of 2.6 Å (Figs 1 and S2 and Table 1). Visual inspection of the density maps of both complexes agrees with the global resolution estimations (Figs 1 and S3S5 and S1S3 Movies). Based on the maps, we built atomic models for an actomyosin filament consisting of four Act1 molecules and two MyoA molecules and for the non-decorated Act1 filament consisting of five actin subunits (S5 Fig).

As typical for actomyosin cryo-EM structures [23,3235], the resolution of the Act1:MyoA:ELC:MTIP structure decays radially away from the helical axis, having a well-resolved core, consisting of the actin filament and the myosin motor domain, whereas density for the MyoA neck region is weaker, but nevertheless allowed us to locate density for the light chains, ELC and MTIP (Fig 2). The actin core in both of our structures is particularly well-resolved compared to other actin filament structures (S3 and S4 Figs). Thus, the molecular details of F-actin, including the small molecules ADP and jasplakinolide as well as the active site metal and water molecules, can be visualized in greater detail (Fig 1) than in myosin-decorated or undecorated actin filament structures [13,3241]. The majority of the MyoA motor domain is well-ordered, and side chains can be placed into density, especially within the actomyosin interface, allowing analysis of specific contacts between MyoA and Act1 in detail.

thumbnail
Fig 2. A model of the light chains ELC and MTIP bound to MyoA.

(A) An unsharpened map (gray) filtered with LAFTER shows the location of the MyoA motor (blue) and the light chains ELC (magenta) and MTIP (cyan). (B) The Act1:MyoA:ELC:MTIP model in the rigor state shown in the context of the membrane-delimited sub-pellicular compartment. An outline of GAC (dotted lines) in two randomly chosen orientations with approximate dimensions derived from the T. gondii GAC small-angle X-ray scattering (SAXS) low-resolution envelope [16]. (C) Results of single molecule optical tweezer assays are presented. (Upper) A displacement histogram for MyoA:ELC:MTIP at 2.5 μM ATP. Power stroke was determined as the shift in the Gaussian peak from 0 nm (gray line), which has an average ∼4.5 nm. (middle) An attached lifetime histogram for muscle actin-MyoA:ELC:MTIP events measured at 2.5 μM ATP. The detachment rate (grey line) was determined by fitting a single-exponential to the histogram. The event lifetime distribution (middle panel) fitted well to a mono-exponential decay (least squares fit gives a rate constant 4.1 s-1) consistent with detachment being controlled by ATP binding to the rigor complex (at 2.5 uM ATP was 1.4x106 M-1 s-1). (Lower) The panel shows the ensemble average of 598 binding events. Each event was synchronized to its start [arrow] and end point [arrow] defined by the change in system stiffness, determined from the amplitude of a 200 Hz sinusoidal forcing function applied by the optical tweezers. The synchronized data were averaged. The average displacement at the start of the event (~4 nm) is smaller than that at the end of the event (~5.5 nm). This observation implies the power stroke is generated in two phases, ~4 nm followed by a further motion of ~1.5 nm.

https://doi.org/10.1371/journal.ppat.1010408.g002

ELC and MTIP bind to the MyoA neck in a compact manner, presumably stiffening the neck region so it acts as a relatively rigid lever arm (Fig 2), consistent with the requirement of both light chains for maximal actin gliding speed as measured in in vitro motility assays [10,11]. To confirm that our recombinant MyoA:ELC:MTIP complex was fully-functional we measured its ATP-driven power stroke, using single-molecule optical trapping nanometry [42] (see Materials and Methods). The average power-stroke, determined by histogramming the amplitude of many individual actomyosin binding events, was 4.5 +/- 0.4 nm s.e.m. (1535 events from 8 replicates, Fig 2C, upper). The distribution of event lifetimes was monotonic and controlled by the rate of ATP binding to the rigor complex (Fig 2C, middle). Ensemble-averaging of events [43] revealed the power stroke was biphasic, comprising a rapid initial movement of ~4 nm followed by a subsequent movement of ~1.5 nm (Fig 2C, lower). Previous studies, indicate the biphasic nature of the power stroke arises from structural changes associated first with phosphate and later with ADP release [44].

A consequence of the extended and rigid neck region is a space constraint for the actomyosin complex in the sub-pellicular compartment. The MyoA:ELC:MTIP complex would occupy approximately half the distance between the IMC and the plasma membrane (~30 nm; Fig 2B), which is similar to the spacing between thick and thin filaments in vertebrate muscle sarcomeres [45]. In the parasite, when the additional space taken up by the actin filament (diameter ~6.5 nm) and GAC (Dmax in solution ~25 nm; [16]) is considered, it is clear that there must be significant geometric and steric constraints on how the actomyosin complex might be arranged (Fig 2A and 2B). It is possible that the attachment of MyoA via its MTIP light chain to the GAP45:GAP50 complex in the IMC might allow azimuthal movement so the motor domain might approach the actin helix from different angles. Also the structure of GAC may be different in the tightly packed pellicle than in solution. These structural considerations will need to be revisited when the 3D geometry of the full glideosome complex is understood.

The MyoA motor domain has a conserved overall structure with several known subdomains common to functional myosin motors (S6 Fig). The upper and lower 50 kDa subdomains are separated by the actin-binding cleft, which is in a closed conformation in our complex (Fig 3). The central transducer region consists of seven β strands (S6 Fig). The lower 50 kDa subdomain contains a helix-turn-helix (HTH) motif, involved in intimate contacts with Act1, while the rest of the actin-contacting residues are in the hypertrophic cardiomyopathy (HCM) loop and in loops 2, 3, and 4 (Fig 3). The more distal parts, the converter and the relay helix, are involved directly in the conformational change upon the power stroke (Fig 2, [46]). Additionally, class XIV myosins have an N-terminal SH3 domain, the role of which is unclear but could be related to the regulation of myosin function during different stages of the parasite life cycle [47]. Our actomyosin rigor structure shows that neither the SH3 domain nor the N-terminal helix is in direct contact with the actin filament and the closest segments are about 18 Å away (Fig 3).

thumbnail
Fig 3. Molecular interactions of MyoA with Act1.

(A) MyoA is shown as cartoon and Act1 as surface representation. The two adjacent actin protomers are colored with distinct colors. The MyoA motifs contributing to the interface as well as MyoA subdomains, and the N-terminal helix and SH3 domain are highlighted and labeled. (B) The HCM-loop lies on one actin protomer, contacting actin SD1. The basic loop 2 (Lys632 and Lys634) interacts with the acidic N-terminus of Act1. (C) The HTH motif in the lower 50K domain contributes most specific hydrogen bonds in the interface, interacting with the D-loop (SD2) and the C-terminal patch of Act1 between SD1 and SD3 in close vicinity of the D-loop in the adjacent actin subunit. (D) Loop 3 and the HTH motif visualized approximately 190° rotated with respect to panel A. Loop 3 (576–577) interacts with the adjacent actin monomer on SD1. The activation loop in the lower 50K domain protrudes towards the next SD1, with Lys534 interacting with the actin N-terminus.

https://doi.org/10.1371/journal.ppat.1010408.g003

Overall, the MyoA structure in complex with actin is very similar (with an overall root mean square deviation (r.m.s.d.) for the Cα positions ~1.3 Å) to the rigor-like conformer found as one of the molecules in the asymmetric unit in the recently determined MyoA crystal structure [20]. However, there are several small but important changes in the complex. Notable differences allow interactions and avoid clashes with actin, including movement of the HCM loop (Ile409-Arg422) by nearly 4 Å, slightly smaller shifts in loop 4 (Glu369-Ala380), loop 3 (Pro572-Phe581), and the HTH motif (Val538-Asn563) as well as the ordering of loop 2 (Lys632-Ser639), which is not visible in the truncated MyoA crystal structure [20], but can be seen in the full-length complex with light chains [21]. In addition, there are several smaller rearrangements in more distal areas, in particular in the converter domain. The N-terminal helix, which is specific to apicomplexan MyoAs and accommodates the phosphorylated Ser19, is stacked between the SH3 domain and the motor domain, suggesting an important structural or functional role (Figs 3 and S6; [20]). The phosphorylation of Ser19 in the MyoA:MTIP:ELC complex is visible in the density map (Fig 1) and was confirmed using mass spectrometry, showing ~50% phosphorylation of the relevant peptide. In the crystal structure of T. gondii MyoA, the entire N-terminal helical extension is not visible in the electron density map [19] but is seen in most MyoA crystal structures [20,21] and MyoA:Act1 complex [23]. The MyoA:Act1 complex described by Robert-Paganin et al. (2021) has slightly different helical parameters, half a degree in twist and 1 Å smaller rise. The largest differences are in the HCM loop and at the tip of HLH with overall r.m.s.d. ~1.4 Å.

Naked Act1 and myosin decorated Act1 filaments are nearly identical

We reconstructed the Act1 filament alone and obtained helical parameters that were similar to our Act1:MyoA complex (Table 1) with a similar rise and a 0.7° smaller azimuthal rotation for the complex. As previously noted for other actomyosin complexes [23,32,33,35], neither MyoA nor Act1 undergo large conformational changes when compared to the structures in isolation, and actin subunits superpose well over 372 residues (RMDS 0.34 Å). However, our highly-resolved density of the Act1 filament allows us to see most of the side chain orientations and details of ligand binding for ADP•Mg2+ and jasplakinolide, as well as putative water molecules, including several in the vicinity of the active site (Figs 1 and 5 and S4 Movie). Active sites of filamentous Act1 or Act1:MyoA filament models are nearly identical, showing presence of ADP and its coordinated magnesium ion.

The Act1 filament has an internal cavity, which is extended towards the filament exterior (Fig 4A and S4 Movie). We modelled density in the cavity as a chain of water molecules (Fig 5), but we cannot exclude presence of other solute molecules. The end of the cavity is formed by the side chains of Asn116 and Trp80 (Fig 4 and S4 Movie). In monomeric Act1, the cavity is much shorter compared to the F-form (Fig 4C). In muscle F-actin, the cavity is limited by the bulkier Ile76 instead of Val77 in Act1 (Fig 4). Notably, residue 76/77 is an Ile in α- and γ-actins, but is also Val in β-actin as well as plant and yeast actins, which release phosphate faster than muscle actin [48,49]. We have previously noted the importance of Gly115 substitution to alanine in Act1; alanine at this position slows down phosphate release compared to glycine, in particular in the Mg-bound form [15,28]. In skeletal or smooth muscle α-actin, Asn115 and Arg116 are sites of disease-associated mutations (N115S, N115T, R116Q, R116H) [50,51]. In yeast, mutations N115T and R116Q affect both nucleotide exchange as well as polymerization kinetics, in particular in the nucleation phase [52]. Therefore, these features of Act1 active site may be relevant to understand actins generally.

thumbnail
Fig 4. Internal cavities in filamentous and monomeric actin structures.

The internal cavities were calculated using the CASTp server [74] and visualized as transparent surfaces using Chimera [66]. (left) The internal cavity in the Act1 filament and (middle) the corresponding channel in monomeric Act1 (4cbu; [15]). (right) The corresponding cavity in muscle actin (6djm; [38]) is shorter due to change from Ile76 to Val77 in Act1.

https://doi.org/10.1371/journal.ppat.1010408.g004

thumbnail
Fig 5. Details of the nucleotide binding site in the Act1 filament.

(left) Density map around the nucleotide-binding site, including ADP (sticks), Mg2+ (green sphere) with coordinating water molecules and putative water molecules (red spheres) in the internal cavity. (right) Schematic presentation of ADP interactions in the filamentous Act1 active site.

https://doi.org/10.1371/journal.ppat.1010408.g005

Based on crystal structures of monomeric actin, the side chain of Ser15 (14 in canonical actins) has been established as a nucleotide sensor, which is turned away from bound ATP but hydrogen bonded to the β-phosphate of ADP [53]. In our structure of the ADP-bound filamentous Act1, the side chain of Ser15 points away from the nucleotide, not contacting the ADP phosphates, thus more closely resembling the conformation in crystal structures of the ATP-bound state (Fig 5). Instead, the Ser15 main chain NH group interacts with the β-phosphate.

Actomyosin interface has conserved features

The MyoA domain architecture is conserved, as in other myosins, regardless of the myosin class (Figs 2 and 3), but residues in the actin-binding interface are generally not conserved (S6 and S7 Figs). The Act1 surface is relatively flat, and thus MyoA lacks large protrusions, which would penetrate deep into the filament pockets (Fig 3A). The interface is mainly formed by contacts between the HTH motif, the HCM loop, and loops 2, 3, and 4 (Fig 3) similarly to previous structures [23,34,35,46]. We analyzed several actomyosin filament structures in the rigor conformation (S7 Fig) by structure-based sequence alignment (DALI, [54]) of the motor domains and compared the fractional buried surface area (PDBePISA, [55]) of MyoA residues in the actin contacting segments. Although, most interacting amino acids are not conserved among different myosin classes, especially in loops 2,3 and 4 (S6 Fig), they have a strikingly conserved pattern of buried surface area within the actin interface (horizontal blue bars in S7 Fig). Interestingly, when we set a threshold for interface residues that are >25% buried in all six myosins, a common interface consists of nine residues (long horizontal red boxes; Thr412, Ala414, Ile419, Gly421, Asp544, Leu547, Ala548, Pro550, Ile635) mostly contacts from HCM-loop and HLH substructures.

Recently, Robert-Paganin et al. (2021) defined conserved (15 residues) and ancillary (9 residues) interface in MyoA (green and cyan boxes in S7 Fig, respectively). Their conserved interface partially overlaps with our analysis, but our core interface consists of 9 residues. Additionally, we noted that each respective myosin motor makes extensive contacts with actin that are not present in the other myosins (gray boxes and yellow-highlighting in S7 Fig), which we summarize here. Within loop 3, Myo 1b has extensive contacts with actin that are not present in other myosins. In loop 4, MyoA uses it to interface actin more (yellow-shaded box) similarly to Myo 6. At the end of loop 2, Myo 7 has an additional patch of non-charged residues in addition to a charged-patch within loop 4. Within the activation loop of the HLH motif, Myo 2c has more interfacing residues; we noted double proline, and three additional residues at loop 2. The HCM-loop is 5 residues longer in Myo 6 than others, and the tip of loop makes extensive contacts with actin.

Helix-Turn-Helix (HTH) interactions

In MyoA, the majority of specific contacts are formed by the HTH motif in the lower 50K domain, which contacts the actin-actin interface (buried surface area 554 Å2), where the D-loop of one actin inserts into the cleft between subdomains 1 and 3 of the adjacent actin (Fig 3B and 3C). The first half of the HTH motif (Ser540-Gly550) forms extensive contacts with both actin subunits, whereas the latter part (Gly551- Lys565) interacts mostly with the D-loop. The Asp544 side chain of MyoA forms hydrogen bonds with the backbone amine of Thr352 in Act1 and the side-chain or backbone amine of Ser351. Asp544 also interacts via its backbone carbonyl with the backbone amine of Ala548 in MyoA. This interaction network between Act1 and MyoA occurs just before the kink in the relay helix, possibly stabilizing it. The tip of the HTH motif (Ala548-Pro549-Gly550) inserts into a hydrophobic cleft in Act1, lined by Ile347-Leu352 and Tyr145-Thr150 as well as the D-loop residues Met46-Val47 from the adjacent actin subunit.

Hypertrophic Cardio-Myopathy and other surface loop interactions

The HCM loop (Fig 3B) forms a second important interface to Act1 (buried surface area 284 Å2) that is complementary in shape, and we detect no hydrogen bonds at the interface. Additional contact points are created by loop 2, which is in close proximity to the HCM loop. The backbone atoms of Ile635 and Gly633, hydrogen bond the actin backbone atoms Gly24 and Asp26 respectively and the Ile635 side-chain inserts into a small patch on actin lined by Gly25, Asp26, Ser345, Ile346, and Ser349. The basic loop2 residues; Arg606 (in the strut segment), Lys634, and Lys637 coordinate actin Asp26, Asp25, and Ser349/Ser351, respectively, with distances ranging between 3.8 and 4.5 Å. The TEDS phosphorylation site [56] Thr417, located at the tip of the HCM-loop, is solvent accessible, and the density map suggests that it is not phosphorylated. Interestingly, our structural study of the actomosin complex did not require phosphomimetic mutation Thr417Asp in contrast to studies of the truncated MyoA [23], which results in a shift of the position of the HCM loop with respect to MyoA, and where the aspartic acid contributes buried surface area to the interaction.

Loop 3 has a small interaction point with Act1 sub-domain I, mediated by Val575/Ala576 in MyoA and Tyr92/Asn93 in actin. Finally, Loop 4 residues, Ala373-Asp377, have extensive interactions with Act1 throughout Lys329 to Glu335.

Concluding remarks

The malaria parasite actomyosin filament structure reported here will serve as a foundation for understanding gliding motility in Apicomplexa as well as force generation in a variety of actomyosin motor systems. We visualize the actin-myosin interface at high-resolution and also present the structure of the entire core motor complex including the light chains, which are essential for fast motility. In addition, we show that the actomyosin light chain complex produces a power stroke similar to other myosins with two light chains [57]. The extremely well-resolved bare Act1 filament assigns accurate side-chain conformations and reveals new active site features. The structures describe several protein-protein interfaces and will be important tools for evaluating the actomyosin motor as a drug target.

Materials and methods

Optical trap assay

All chemical reagents were obtained from Sigma unless stated otherwise. Experiments were performed using a custom-built optical trapping instrument based around an inverted, Zeiss Axiovert 135 microscope, that has been described previously [44]. Briefly, microscope flow-cells were prepared from a microscope slide and coverslip fixed together with double-sided adhesive tape leaving a flow-channel of ~30 μl volume. Coverslips were previously coated with 2.4 μm diameter glass microspheres diluted into a 0.1% nitrocellulose solution. MyoA:ELC:MTIP was infused into the flow-cell at 1 μg ml-1 in an assay buffer “AB-” containing 25 mM KCl, 25 mM imidazole, 4 mM MgCl2, and 1 mM EGTA, pH 7.4, at ∼23°C. Flow-cell surfaces were then passivated using four chamber volumes of AB− with 1 mg ml-1 BSA. The flow-cell was then infused with “AB+” buffer comprising AB- supplemented 0.3 μM ATP, 2 mM creatine phosphate, 0.1 mg ml-1 creatine kinase, 50 mM DTT, 3 mM glucose, 100 μM glucose oxidase, and 20 μM catalase, 0.2 nM rhodamine-phalloidin labeled, 10% biotinylated, filamentous porcine actin and neutravidin-coated 1μm diameter polystyrene beads. Actin filaments were visualised using 532 nm laser excitation. The incoming 532 nm laser was reflected by a dual-dichroic mirror (532 nm and 1064 nm, Semrock custom dichroic) which also reflected the near infra-red (1064nm) optical trapping laser onto the specimen. Rhodamine fluorescence from the labelled actin was imaged via a 580-640nm bandpass filter using a custom-built, image-intensified CMOS camera. The polystyrene beads were visualised using bright-field optics which allowed a single actin filament (5–7 μm long) to be captured at either end between two beads held in two, independently controlled, optical traps. The so-called “dumbbell” of bead-actin-bead was then held taut and positioned in close proximity to one of the surface-immobilized MyoA:ELC:MTIP coated beads. Under conditions used here only about 1-in-3 of the surface beads produced actomyosin interactions due to the low surface-density of MyoA molecules. Bead positions were measured by projecting their bright-field images onto two, 4-quadrant, photodiode detectors (bandwidth >10kHz, resolution <1nm). Digital data was collected at 10kHz and saved to computer. Optical trap stiffness was 0.02 pN nm-1 and thermal noise, governed by the equipartition principle, was ~15 nm r.m.s. When actin bound the surface-immobilized MyoA positional noise fell dramatically because system stiffness increased to >0.25 pN nm-1 as the actomyosin bond stiffness acts in parallel to the trap stiffness. To increase the time-resolution of our measurements the optical tweezers were moved sinusoidally (50 nm peak-to-peak, 200 Hz) producing a ~12 nm p-p bead motion. Motion was quantified by computing a running discrete Fourier transform (software phase-locked-loop) of the bead motion. This enabled the start- and end-time of individual binding events to be identified with <10 ms jitter so that events could be synchronised in software and averaged to give an ensemble representation of the powerstroke time-course (see [43]).

Preparation of proteins and cryo-EM grids

MyoA:ELC:MTIP and Act1 were expressed and purified as previously described [10,24]. For Act1 samples, ammonium acetate was removed by a spin column, and Act1 (13.1 μM) was polymerized in the presence of 13 μM jasplakinolide by adding 10X KMEI, in final 1x concentration of 10 mM Hepes, pH 7.5, 50 mM KCl, 4 mM MgCl2, 1 mM EGTA. Polymerized filamentous Act1 was diluted down to 0.13 μM, and treated with apyrase (77 μg/ml) for 20 min before addition of the MyoA:ELC:MTIP complex in a 1:1 ratio.

For Act1-only samples, no apyrase was used. After 30 min incubation, negatively stained or cryo-EM grids were prepared. The quality of the decorated filaments was first checked with negative staining, and after confirming the presence of decorated Act1 filaments, frozen-hydrated samples were prepared on Quantifoil 2/2, 200 mesh in-air glow-discharged grids using an Mk III Vitrobot (FEI). 3 μl of sample was applied on a grid and blotted for 3 s before plunge-freezing in liquid ethane.

Act1:MyoA filament

Data consisting of 2815 movies were collected with a Titan Krios electron microscope equipped with a Falcon 3 camera, operated at 300 kV in counting mode. The magnification was 75 000x, corresponding to 1.09 Å pixel-1, using a dose rate of 0.539 e-2s-1 with exposure time of 92 s for a stack of 46 frames. The dose per frame was 1.07 e-2, and we used defoci from 0.8 to 2.6 μm. The movies were aligned with MotionCor2 [58] within the Scipion framework [59]. Contrast transfer function parameters were estimated by CTFFind 4.1.5 [60], and the resulting 2786 good images were used for further data processing. To confirm data processability, we picked decorated filaments by hand and performed low-resolution reconstructions from 2x binned images of a few hundred particles using symmetry parameters defined for Act1 [13] or refined helical symmetry parameters in Relion 2.1 [31,61] using a featureless cylinder as a starting reference. The reconstruction converged to a filamentous structure with protruding densities typical for actomyosin structures. Further inspection revealed that homologous myosin motor domains [34] as well as a filamentous Act1 model (PDB code: 5ogw [13]) fit the density well. Decorated filaments were iteratively picked with Relion autopick using reference-free Relion 2D classes as templates with an inter-box distance of two subunits with a rise of 28 Å. The resulting 381 256 particles were subjected to reference-free 2D classification in Relion, resulting in 239 225 fully decorated actomyosin particles. High-resolution volumes were generated in Relion 2.1 auto-refine using low-resolution models from 2x binned data as a reference. A soft mask was applied to the reference model, and reconstruction was continued from the last iteration. When the reconstruction converged, we continued refinement of the contrast transfer function and subsequent reconstructions with Relion 3 beta for two additional rounds. Refined half-maps were sharpened automatically [62], and global resolution was corrected for the effects of a mask [63] using the Relion postprocessing tool. We estimated local resolution with Blocres in Bsoft package version 1.8.6 with a Fourier shell correlation threshold of 0.3 [64,65].

Act1 filament

We collected 3953 movies with a Titan Krios electron microscope fitted with a Falcon 3 camera in electron counting mode, operated at 300 kV. We used a nominal magnification of 75 000x, corresponding to 1.09 Å pixel-1. Each movie was recorded as 46 frames with 1.17 e-2 dose/frame using defoci from 0.8 to 2.6 μm. The fractionated movies were aligned globally in Relion 3.0.7. Contrast transfer function was estimated by CtfFind 4.1.10 from dose-weighted micrographs. Particles were picked automatically using four times the rise (28 Å). The resulting 336 552 particles were extracted and binned two times at 2.18 Å/pixel in a 328 pixel box before they were subjected to a reference free 2D classification, and resulted in 305 480 particles in the final data set. These particles were re-extracted as unbinned, and processed with Relion auto-refine with a reference mask and solvent flattening from a previous reconstruction (nominal resolution 4.4 Å) low pass filtered to 20 Å. After polishing and contrast transfer function refinement, the resulting map reached an average resolution of 2.6 Å, based on the 0.143 Fourier shell criterion. Visual inspection of the density map features agreed with the resolution estimate. After reconstruction, the map was masked and sharpened by the Relion postprocessing tool.

Model building

Act1:MyoA filament.

Act1 (PDB code 5ogw; [13]) was docked in density using Chimera [66], and we generated four additional symmetry copies. Two copies of the MyoA crystal structure in the rigor-state (PDB code 6i7d; [20]) were placed into the density using Chimera. We iteratively built a model using tools in ISOLDE 1.0b [67], Coot [68], and real-space optimized by Namdinator [69]. The local resolution of the reconstruction was estimated by Blocres [63], Chimera [66], and ChimeraX [70].

In addition, we note that the experimental map is of high quality. Before the MyoA crystal structure became available, we built a complete model of MyoA, de novo, based on a homology model of MyoA, the density map, and myosin models 1DFK and 6C1D [34,71] to guide manual model building. Our de novo MyoA model assigned the sequence register similarly to the X-ray crystal-structure (PDB code: 6i7d) and the last 25 amino acids were better resolved than in the X-ray structure. Additionally, phosphorylation of Ser19 was resolved with the correct sequence register.

Act1 filament

Our previous model of the Act1 filament (PDB code: 5ogw; [13]) was placed in the density map in Chimera [66], and was manually built using model building tools in ISOLDE 1.0b3.dev6 [67], Coot [68], and real-space refinement in Phenix 1.17 [72]. We built five copies of Act1, re-assigning side chain rotamers as required, and waters around Act1 monomers into density. Additionally, we built the active site with the Mg2+-coordinated waters. Density for the Mg2+-water complex was anisotropic, and the Mg2+-coordinated waters were merged into Mg2+-ion density. In order to keep ideal coordination of the water molecules, we created custom restraints for waters to restrain ideal distance and angles to the Mg2+ ion.

Low-resolution model of light-chain-decorated myosin A

Unfiltered 2x binned half-maps were filtered with LAFTER [73], and the MyoA model (6tu7) and a trimeric light chain model (6zn3; [22]) were placed into the filtered LAFTER map.

Supporting information

S1 Fig. Act1:MyoA filaments and resolution reconstruction.

(A) Representative micrographs of MyoA-decorated Act1 filaments. (B) Reference free classes derived from the micrographs. (C) Fourier shell correlation of the Act1:MyoA complex. Using the 0.143 Fourier shell threshold criterion, the global resolution is 3.1 Å. The masked curve was calculated from independently refined half-datasets with a soft-mask filtered to 15 Å.

https://doi.org/10.1371/journal.ppat.1010408.s001

(PDF)

S2 Fig. Examples of the Act1 filaments and resolution reconstruction.

(A) Representative micrographs of Act1 filaments low-pass filtered at absolute frequency 0.15, (B) reference free classes derived from them, and (C) Fourier shell correlation of the Act1 filament. Using the 0.143 Fourier shell threshold criterion, the global resolution is 2.6 Å. The corrected curve was calculated from independently refined half-datasets with a soft-mask filtered to 15 Å in Relion.

https://doi.org/10.1371/journal.ppat.1010408.s002

(PDF)

S3 Fig. Local resolution of the MyoA-decorated Act1 filament.

The local resolution estimation is based on the Fourier shell correlation threshold 0.3 calculated with Blocres in the Bsoft software package, which was displayed on the final sharpened map.

https://doi.org/10.1371/journal.ppat.1010408.s003

(PDF)

S4 Fig. Local resolution of the Act1 filament.

The local resolution estimation is based on Fourier shell correlation threshold 0.3 calculated with Blocres in the Bsoft software package, displayed on the final sharpened map. The left panel shows a central section of the filament, and the right panel shows an individual actin protomer with the ligand densities highlighted.

https://doi.org/10.1371/journal.ppat.1010408.s004

(PDF)

S5 Fig. Density maps of the Act1:MyoA complex and the individual sub-units.

https://doi.org/10.1371/journal.ppat.1010408.s005

(PDF)

S6 Fig. Structural domains and sequence comparison of the MyoA motor domain.

(Upper panel) The MyoA motor domain in two slightly different orientations to display the different functional motifs, shown in different colors and labeled. (Lower panel) In the structure-based sequence alignment, strictly conserved residues have red background, more than 70% identical residues are red in a blue frame. Amino acids in the actomyosin interface are indicated with cyan shading. Above the sequence, the actin-contacting structural motifs are indicated. The black bars under the sequence show fractional buried surface area for MyoA residues (1 bar <30%, 2 bars 30%-60%, 3 bars >60%). The sequence alignment is based on pairwise structural alignment against MyoA using the DALI server [Holm L. DALI and the persistence of protein shape. Protein Sci. 2020;29(1):128–40. Epub 2019/10/14. doi: 10.1002/pro.3749] [54], and further annotated using the ESPript 3.0 web interface [Robert X, Gouet P. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res. 2014;42(Web Server issue):W320-4] [75].

https://doi.org/10.1371/journal.ppat.1010408.s006

(PDF)

S7 Fig. Buried surface areas of different actomyosin complexes in the rigor conformation.

Actomyosin structures were analyzed using PDBePISA [Krissinel E, Henrick K. Inference of macromolecular assemblies from crystalline state. J Mol Biol. 2007;372(3):774–97] [55]. A structure-based sequence alignment for each myosin is shown in the vertical column. The fractional buried surface area is shown for each amino acid residue in the actin interface. Long horizontal red boxes show common interfaces (fractional BSA >25% in all six structures). Grey boxes highlight additional interactions, which are discussed in the main text. Green and magenta boxes around amino acid residues indicate conserved and ancillary, respectively, interfaces, as defined by Robert-Paganin et al. [23].

https://doi.org/10.1371/journal.ppat.1010408.s007

(PDF)

S1 Movie. The Act1:MyoA map colored by local resolution.

First, the malaria parasite actomyosin complex is rotated around the helical axis to present the overall quality of the map used to build the actomyosin model. The latter part of the movie shows the maps for a longitudinal Act1 dimer and MyoA separately. The slider on the right indicates the color code for the resolution in different parts of the map from 2.5 (blue) to 4.5 Å (red).

https://doi.org/10.1371/journal.ppat.1010408.s008

(MOV)

S2 Movie. Quality of the Act1:MyoA map.

First, the MyoA-decorated filament is rotated around the helical axis, demonstrating high-resolution electron density, in which the majority of side chains are visible, sufficient for de novo atomic model building. In the latter part of the movie, each of the central protein subunits (4 actins and 2 myosins) is depicted with a different color. Jasplakinolide, located between actin subunits, is shown in red and ADP in the cleft between the actin subdomains is shown in yellow.

https://doi.org/10.1371/journal.ppat.1010408.s009

(MOV)

S3 Movie. High-resolution map of the Act1 filament colored by local resolution.

First, the filament is rotated around the helical axis, demonstrating high-resolution features. The latter part of the movie shows a single actin protomer. The slider on the right indicates the color code for the resolution in different parts of the map from 2.3 (magenta) to 2.9 Å (cyan).

https://doi.org/10.1371/journal.ppat.1010408.s010

(MP4)

S4 Movie. A cross-section of Act1 showing the internal channel extending from the nucleotide binding pocket towards Asn116 and Trp80 on the surface.

The Act1 model is shown as surface representation, and the plane of view sections through the internal void revealing putative waters (red spheres) and ADP (sticks).

https://doi.org/10.1371/journal.ppat.1010408.s011

(MP4)

S1 Data. Raw data related to the optical trapping experiments presented in Fig 2.

https://doi.org/10.1371/journal.ppat.1010408.s012

(XLSX)

Acknowledgments

We thank the Francis Crick Structural Biology Scientific Technology Platform for instrument access and computing support: Andrea Nans for help with data cryo-EM data collection, and Phil Walker, Andy Purkiss, and Andrea Nans for help with computing. We thank Donald Benton and Oliver Acton for helpful advice with image processing and Ulrich Bergmann from the Proteomics and Protein Analysis Core Facility at the Biocenter Oulu for mass spectrometry.

References

  1. 1. WHO. World malaria report 2020: 20 years of global progress and challenges. Geneva: 2020.
  2. 2. Frenal K, Dubremetz JF, Lebrun M, Soldati-Favre D. Gliding motility powers invasion and egress in Apicomplexa. Nat Rev Microbiol. 2017;15(11):645–60. Epub 2017/09/05. pmid:28867819.
  3. 3. Heintzelman MB. Gliding motility in apicomplexan parasites. Semin Cell Dev Biol. 2015;46:135–42. Epub 2015/10/03. pmid:26428297.
  4. 4. Kumpula EP, Kursula I. Towards a molecular understanding of the apicomplexan actin motor: on a road to novel targets for malaria remedies? Acta Crystallogr F Struct Biol Commun. 2015;71(Pt 5):500–13. Epub 2015/05/07. pmid:25945702; PubMed Central PMCID: PMC4427158.
  5. 5. Sebe-Pedros A, Grau-Bove X, Richards TA, Ruiz-Trillo I. Evolution and classification of myosins, a paneukaryotic whole-genome approach. Genome Biol Evol. 2014;6(2):290–305. Epub 2014/01/21. pmid:24443438; PubMed Central PMCID: PMC3942036.
  6. 6. Kato Y, Miyakawa T, Tanokura M. Overview of the mechanism of cytoskeletal motors based on structure. Biophys Rev. 2018;10(2):571–81. Epub 2017/12/14. pmid:29235081; PubMed Central PMCID: PMC5899727.
  7. 7. Preller M, Manstein DJ. Myosin structure, allostery, and mechano-chemistry. Structure. 2013;21(11):1911–22. Epub 2013/11/12. pmid:24210227.
  8. 8. Sellers JR. Myosins: a diverse superfamily. Biochim Biophys Acta. 2000;1496(1):3–22. Epub 2000/03/21. pmid:10722873.
  9. 9. Wall RJ, Zeeshan M, Katris NJ, Limenitakis R, Rea E, Stock J, et al. Systematic analysis of Plasmodium myosins reveals differential expression, localisation, and function in invasive and proliferative parasite stages. Cell Microbiol. 2019;21(10):e13082. Epub 2019/07/10. pmid:31283102; PubMed Central PMCID: PMC6851706.
  10. 10. Green JL, Wall RJ, Vahokoski J, Yusuf NA, Ridzuan MAM, Stanway RR, et al. Compositional and expression analyses of the glideosome during the Plasmodium life cycle reveal an additional myosin light chain required for maximum motility. J Biol Chem. 2017;292(43):17857–75. Epub 2017/09/13. pmid:28893907; PubMed Central PMCID: PMC5663884.
  11. 11. Bookwalter CS, Tay CL, McCrorie R, Previs MJ, Lu H, Krementsova EB, et al. Reconstitution of the core of the malaria parasite glideosome with recombinant Plasmodium class XIV myosin A and Plasmodium actin. J Biol Chem. 2017;292(47):19290–303. Epub 2017/10/06. pmid:28978649; PubMed Central PMCID: PMC5702669.
  12. 12. Green JL, Martin SR, Fielden J, Ksagoni A, Grainger M, Yim Lim BY, et al. The MTIP-myosin A complex in blood stage malaria parasites. J Mol Biol. 2006;355(5):933–41. Epub 2005/12/13. pmid:16337961.
  13. 13. Pospich S, Kumpula EP, von der Ecken J, Vahokoski J, Kursula I, Raunser S. Near-atomic structure of jasplakinolide-stabilized malaria parasite F-actin reveals the structural basis of filament instability. Proc Natl Acad Sci U S A. 2017;114(40):10636–41. Epub 2017/09/20. pmid:28923924; PubMed Central PMCID: PMC5635891.
  14. 14. Schmitz S, Grainger M, Howell S, Calder LJ, Gaeb M, Pinder JC, et al. Malaria parasite actin filaments are very short. J Mol Biol. 2005;349(1):113–25. Epub 2005/05/07. pmid:15876372.
  15. 15. Vahokoski J, Bhargav SP, Desfosses A, Andreadaki M, Kumpula EP, Martinez SM, et al. Structural differences explain diverse functions of Plasmodium actins. PLoS Pathog. 2014;10(4):e1004091. Epub 2014/04/20. pmid:24743229; PubMed Central PMCID: PMC3990709.
  16. 16. Jacot D, Tosetti N, Pires I, Stock J, Graindorge A, Hung YF, et al. An Apicomplexan Actin-Binding Protein Serves as a Connector and Lipid Sensor to Coordinate Motility and Invasion. Cell Host Microbe. 2016;20(6):731–43. Epub 2016/12/16. pmid:27978434.
  17. 17. Kappe S, Bruderer T, Gantt S, Fujioka H, Nussenzweig V, Menard R. Conservation of a gliding motility and cell invasion machinery in Apicomplexan parasites. J Cell Biol. 1999;147(5):937–44. Epub 1999/12/01. pmid:10579715; PubMed Central PMCID: PMC2169348.
  18. 18. Farrow RE, Green J, Katsimitsoulia Z, Taylor WR, Holder AA, Molloy JE. The mechanism of erythrocyte invasion by the malarial parasite, Plasmodium falciparum. Semin Cell Dev Biol. 2011;22(9):953–60. Epub 2011/10/18. pmid:22001249.
  19. 19. Powell CJ, Ramaswamy R, Kelsen A, Hamelin DJ, Warshaw DM, Bosch J, et al. Structural and mechanistic insights into the function of the unconventional class XIV myosin MyoA from Toxoplasma gondii. Proc Natl Acad Sci U S A. 2018;115(45):E10548–E55. Epub 2018/10/24. pmid:30348763; PubMed Central PMCID: PMC6233092.
  20. 20. Robert-Paganin J, Robblee JP, Auguin D, Blake TCA, Bookwalter CS, Krementsova EB, et al. Plasmodium myosin A drives parasite invasion by an atypical force generating mechanism. Nat Commun. 2019;10(1):3286. Epub 2019/07/25. pmid:31337750; PubMed Central PMCID: PMC6650474.
  21. 21. Moussaoui D, Robblee JP, Auguin D, Krementsova EB, Haase S, Blake TCA, et al. Full-length Plasmodium falciparum myosin A and essential light chain PfELC structures provide new anti-malarial targets. Elife. 2020;9. Epub 2020/10/14. pmid:33046215; PubMed Central PMCID: PMC7553781.
  22. 22. Pazicky S, Dhamotharan K, Kaszuba K, Mertens HDT, Gilberger T, Svergun D, et al. Structural role of essential light chains in the apicomplexan glideosome. Commun Biol. 2020;3(1):568. Epub 2020/10/15. pmid:33051581; PubMed Central PMCID: PMC7555893.
  23. 23. Robert-Paganin J, Xu XP, Swift MF, Auguin D, Robblee JP, Lu H, et al. The actomyosin interface contains an evolutionary conserved core and an ancillary interface involved in specificity. Nat Commun. 2021;12(1):1892. Epub 2021/03/27. pmid:33767187; PubMed Central PMCID: PMC7994445.
  24. 24. Kumpula EP, Pires I, Lasiwa D, Piirainen H, Bergmann U, Vahokoski J, et al. Apicomplexan actin polymerization depends on nucleation. Sci Rep. 2017;7(1):12137. Epub 2017/09/25. pmid:28939886; PubMed Central PMCID: PMC5610305.
  25. 25. Lu H, Fagnant PM, Trybus KM. Unusual dynamics of the divergent malaria parasite PfAct1 actin filament. Proc Natl Acad Sci U S A. 2019;116(41):20418–27. Epub 2019/09/25. pmid:31548388; PubMed Central PMCID: PMC6789906.
  26. 26. Stortz JF, Del Rosario M, Singer M, Wilkes JM, Meissner M, Das S. Formin-2 drives polymerisation of actin filaments enabling segregation of apicoplasts and cytokinesis in Plasmodium falciparum. Elife. 2019;8. Epub 2019/07/20. pmid:31322501; PubMed Central PMCID: PMC6688858.
  27. 27. Skillman KM, Ma CI, Fremont DH, Diraviyam K, Cooper JA, Sept D, et al. The unusual dynamics of parasite actin result from isodesmic polymerization. Nat Commun. 2013;4:2285. Epub 2013/08/08. pmid:23921463; PubMed Central PMCID: PMC3765016.
  28. 28. Kumpula EP, Lopez AJ, Tajedin L, Han H, Kursula I. Atomic view into Plasmodium actin polymerization, ATP hydrolysis, and fragmentation. PLoS Biol. 2019;17(6):e3000315. pmid:31199804
  29. 29. Lammermann T, Afonso PV, Angermann BR, Wang JM, Kastenmuller W, Parent CA, et al. Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo. Nature. 2013;498(7454):371–5. Epub 2013/05/28. pmid:23708969; PubMed Central PMCID: PMC3879961.
  30. 30. Hopp CS, Chiou K, Ragheb DR, Salman AM, Khan SM, Liu AJ, et al. Longitudinal analysis of Plasmodium sporozoite motility in the dermis reveals component of blood vessel recognition. Elife. 2015;4. Epub 2015/08/14. pmid:26271010; PubMed Central PMCID: PMC4594146.
  31. 31. He S, Scheres SHW. Helical reconstruction in RELION. J Struct Biol. 2017;198(3):163–76. Epub 2017/02/15. pmid:28193500; PubMed Central PMCID: PMC5479445.
  32. 32. Fujii T, Namba K. Structure of actomyosin rigour complex at 5.2 A resolution and insights into the ATPase cycle mechanism. Nat Commun. 2017;8:13969. Epub 2017/01/10. pmid:28067235; PubMed Central PMCID: PMC5227740.
  33. 33. Gurel PS, Kim LY, Ruijgrok PV, Omabegho T, Bryant Z, Alushin GM. Cryo-EM structures reveal specialization at the myosin VI-actin interface and a mechanism of force sensitivity. Elife. 2017;6. Epub 2017/12/05. pmid:29199952; PubMed Central PMCID: PMC5762158.
  34. 34. Mentes A, Huehn A, Liu X, Zwolak A, Dominguez R, Shuman H, et al. High-resolution cryo-EM structures of actin-bound myosin states reveal the mechanism of myosin force sensing. Proc Natl Acad Sci U S A. 2018;115(6):1292–7. Epub 2018/01/24. pmid:29358376; PubMed Central PMCID: PMC5819444.
  35. 35. von der Ecken J, Heissler SM, Pathan-Chhatbar S, Manstein DJ, Raunser S. Cryo-EM structure of a human cytoplasmic actomyosin complex at near-atomic resolution. Nature. 2016;534(7609):724–8. Epub 2016/06/22. pmid:27324845.
  36. 36. Merino F, Pospich S, Funk J, Wagner T, Kullmer F, Arndt HD, et al. Structural transitions of F-actin upon ATP hydrolysis at near-atomic resolution revealed by cryo-EM. Nat Struct Mol Biol. 2018;25(6):528–37. Epub 2018/06/06. pmid:29867215.
  37. 37. von der Ecken J, Muller M, Lehman W, Manstein DJ, Penczek PA, Raunser S. Structure of the F-actin-tropomyosin complex. Nature. 2015;519(7541):114–7. Epub 2014/12/04. pmid:25470062; PubMed Central PMCID: PMC4477711.
  38. 38. Chou SZ, Pollard TD. Mechanism of actin polymerization revealed by cryo-EM structures of actin filaments with three different bound nucleotides. Proc Natl Acad Sci U S A. 2019;116(10):4265–74. Epub 2019/02/15. pmid:30760599; PubMed Central PMCID: PMC6410863.
  39. 39. Chou SZ, Pollard TD. Cryo-electron microscopy structures of pyrene-labeled ADP-Pi- and ADP-actin filaments. Nat Commun. 2020;11(1):5897. Epub 2020/11/21. pmid:33214556; PubMed Central PMCID: PMC7677365.
  40. 40. Oda T, Yanagisawa H, Wakabayashi T. Cryo-EM structures of cardiac thin filaments reveal the 3D architecture of troponin. J Struct Biol. 2020;209(3):107450. Epub 2020/01/20. pmid:31954841.
  41. 41. Pospich S, Kullmer F, Nasufovic V, Funk J, Belyy A, Bieling P, et al. Cryo-EM Resolves Molecular Recognition Of An Optojasp Photoswitch Bound To Actin Filaments In Both Switch States. Angew Chem Int Ed Engl. 2021. Epub 2021/01/16. pmid:33449370.
  42. 42. Molloy JE, Burns JE, Kendrick-Jones J, Tregear RT, White DC. Movement and force produced by a single myosin head. Nature. 1995;378(6553):209–12. Epub 1995/11/09. pmid:7477328.
  43. 43. Veigel C, Coluccio LM, Jontes JD, Sparrow JC, Milligan RA, Molloy JE. The motor protein myosin-I produces its working stroke in two steps. Nature. 1999;398(6727):530–3. Epub 1999/04/17. pmid:10206648.
  44. 44. Takagi Y, Farrow RE, Billington N, Nagy A, Batters C, Yang Y, et al. Myosin-10 produces its power-stroke in two phases and moves processively along a single actin filament under low load. Proc Natl Acad Sci U S A. 2014;111(18):E1833–42. Epub 2014/04/23. pmid:24753602; PubMed Central PMCID: PMC4020102.
  45. 45. Luther P, Squire J. Three-dimensional structure of the vertebrate muscle M-region. J Mol Biol. 1978;125(3):313–24. Epub 1978/11/05. pmid:731697.
  46. 46. Robert-Paganin J, Pylypenko O, Kikuti C, Sweeney HL, Houdusse A. Force Generation by Myosin Motors: A Structural Perspective. Chem Rev. 2020;120(1):5–35. Epub 2019/11/07. pmid:31689091.
  47. 47. Mueller C, Graindorge A, Soldati-Favre D. Functions of myosin motors tailored for parasitism. Curr Opin Microbiol. 2017;40:113–22. Epub 2017/11/22. pmid:29161623.
  48. 48. Kijima ST, Hirose K, Kong SG, Wada M, Uyeda TQ. Distinct Biochemical Properties of Arabidopsis thaliana Actin Isoforms. Plant Cell Physiol. 2016;57(1):46–56. Epub 2015/11/19. pmid:26578694.
  49. 49. Ti SC, Pollard TD. Purification of actin from fission yeast Schizosaccharomyces pombe and characterization of functional differences from muscle actin. J Biol Chem. 2011;286(7):5784–92. Epub 2010/12/15. pmid:21148484; PubMed Central PMCID: PMC3037691.
  50. 50. Costa CF, Rommelaere H, Waterschoot D, Sethi KK, Nowak KJ, Laing NG, et al. Myopathy mutations in alpha-skeletal-muscle actin cause a range of molecular defects. J Cell Sci. 2004;117(Pt 15):3367–77. Epub 2004/07/01. pmid:15226407.
  51. 51. Sparrow JC, Nowak KJ, Durling HJ, Beggs AH, Wallgren-Pettersson C, Romero N, et al. Muscle disease caused by mutations in the skeletal muscle alpha-actin gene (ACTA1). Neuromuscul Disord. 2003;13(7–8):519–31. Epub 2003/08/19. pmid:12921789.
  52. 52. Bergeron SE, Wedemeyer EW, Lee R, Wen KK, McKane M, Pierick AR, et al. Allele-specific effects of thoracic aortic aneurysm and dissection alpha-smooth muscle actin mutations on actin function. J Biol Chem. 2011;286(13):11356–69. Epub 2011/02/04. pmid:21288906; PubMed Central PMCID: PMC3064192.
  53. 53. Rould MA, Wan Q, Joel PB, Lowey S, Trybus KM. Crystal structures of expressed non-polymerizable monomeric actin in the ADP and ATP states. J Biol Chem. 2006;281(42):31909–19. Epub 2006/08/22. pmid:16920713.
  54. 54. Holm L. DALI and the persistence of protein shape. Protein Sci. 2020;29(1):128–40. Epub 2019/10/14. pmid:31606894; PubMed Central PMCID: PMC6933842.
  55. 55. Krissinel E, Henrick K. Inference of macromolecular assemblies from crystalline state. J Mol Biol. 2007;372(3):774–97. Epub 2007/08/08. pmid:17681537.
  56. 56. Bement WM, Mooseker MS. TEDS rule: a molecular rationale for differential regulation of myosins by phosphorylation of the heavy chain head. Cell Motil Cytoskeleton. 1995;31(2):87–92. Epub 1995/01/01. pmid:7553910
  57. 57. Ruff C, Furch M, Brenner B, Manstein DJ, Meyhofer E. Single-molecule tracking of myosins with genetically engineered amplifier domains. Nat Struct Biol. 2001;8(3):226–9. Epub 2001/02/27. pmid:11224566.
  58. 58. Zheng SQ, Palovcak E, Armache JP, Verba KA, Cheng Y, Agard DA. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat Methods. 2017;14(4):331–2. Epub 2017/03/03. pmid:28250466; PubMed Central PMCID: PMC5494038.
  59. 59. Gomez-Blanco J, de la Rosa-Trevin JM, Marabini R, Del Cano L, Jimenez A, Martinez M, et al. Using Scipion for stream image processing at Cryo-EM facilities. J Struct Biol. 2018. Epub 2018/10/09. pmid:30296492.
  60. 60. Rohou A, Grigorieff N. CTFFIND4: Fast and accurate defocus estimation from electron micrographs. J Struct Biol. 2015;192(2):216–21. Epub 2015/08/19. pmid:26278980.
  61. 61. Scheres SH. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J Struct Biol. 2012;180(3):519–30. Epub 2012/09/25. pmid:23000701; PubMed Central PMCID: PMC3690530.
  62. 62. Rosenthal PB, Henderson R. Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy. J Mol Biol. 2003;333(4):721–45. Epub 2003/10/22. pmid:14568533.
  63. 63. Chen S, McMullan G, Faruqi AR, Murshudov GN, Short JM, Scheres SH, et al. High-resolution noise substitution to measure overfitting and validate resolution in 3D structure determination by single particle electron cryomicroscopy. Ultramicroscopy. 2013;135:24–35. Epub 2013/07/23. pmid:23872039; PubMed Central PMCID: PMC3834153.
  64. 64. Cardone G, Heymann JB, Steven AC. One number does not fit all: mapping local variations in resolution in cryo-EM reconstructions. J Struct Biol. 2013;184(2):226–36. Epub 2013/08/21. pmid:23954653; PubMed Central PMCID: PMC3837392.
  65. 65. Heymann JB, Belnap DM. Bsoft: image processing and molecular modeling for electron microscopy. J Struct Biol. 2007;157(1):3–18. Epub 2006/10/03. pmid:17011211.
  66. 66. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF Chimera—a visualization system for exploratory research and analysis. J Comput Chem. 2004;25(13):1605–12. Epub 2004/07/21. pmid:15264254.
  67. 67. Croll TI. ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps. Acta Crystallogr D Struct Biol. 2018;74(Pt 6):519–30. Epub 2018/06/07. pmid:29872003; PubMed Central PMCID: PMC6096486.
  68. 68. Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Crystallogr D Biol Crystallogr. 2010;66(Pt 4):486–501. Epub 2010/04/13. pmid:20383002; PubMed Central PMCID: PMC2852313.
  69. 69. Kidmose RT, Juhl J, Nissen P, Boesen T, Karlsen JL, Pedersen BP. Namdinator—automatic molecular dynamics flexible fitting of structural models into cryo-EM and crystallography experimental maps. IUCrJ. 2018;6(Pt 4):526–31.
  70. 70. Goddard TD, Huang CC, Meng EC, Pettersen EF, Couch GS, Morris JH, et al. UCSF ChimeraX: Meeting modern challenges in visualization and analysis. Protein Sci. 2018;27(1):14–25. Epub 2017/07/16. pmid:28710774; PubMed Central PMCID: PMC5734306.
  71. 71. Houdusse A, Szent-Gyorgyi AG, Cohen C. Three conformational states of scallop myosin S1. Proc Natl Acad Sci U S A. 2000;97(21):11238–43. Epub 2000/10/04. pmid:11016966; PubMed Central PMCID: PMC17184.
  72. 72. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr. 2010;66(Pt 2):213–21. Epub 2010/02/04. pmid:20124702; PubMed Central PMCID: PMC2815670.
  73. 73. Ramlaul K, Palmer CM, Aylett CHS. A Local Agreement Filtering Algorithm for Transmission EM Reconstructions. J Struct Biol. 2019;205(1):30–40. Epub 2018/12/06. pmid:30502495; PubMed Central PMCID: PMC6351148.
  74. 74. Tian W, Chen C, Lei X, Zhao J, Liang J. CASTp 3.0: computed atlas of surface topography of proteins. Nucleic Acids Res. 2018;46(W1):W363–W7. Epub 2018/06/04. pmid:29860391; PubMed Central PMCID: PMC6031066.
  75. 75. Robert X, Gouet P. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res. 2014;42(Web Server issue):W320–4. pmid:24753421